Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by hevinon Jan 06, 2022 11:26am
232 Views
Post# 34289168

RE:Entertaining bunch here

RE:Entertaining bunch hereWelcome back on board a ship which has been being slowly sunk by shorty and their minions who never mention European aspects for last eight months with regulators doing zero about it. I won't guess rev this time around, but with another 1% drop in market share to 11.7 I suspect your estimate might be a touch high, but like everyone here, I have no clue. Not even sure we're not overvalued at the current SP if you consider market cap to gross rev. At nearly 4 to 1, I believe that is considered too high, although I defer to the experts. Read somewhere that 2 to 1 or less is a good deal. Again unsure. Also with German legalization not coming soon enough and the US potentially in permanent gridlock, not seeing many catalysts. Meanwhile Irwin is not impressing me right now as we keep losing market share instead of stealing it especially considering we're supposedly the lowest cost producer. I'm still a bull but the event horizon appears further away to me than it did a few months ago unfortunately. Hope that helps and I don't want to be a buzz kill just a realist. Glta longs, shorty karma going to get them sooner or later.
slottygoddy wrote: Been watching you folks for a while, along with some of you on Twitter.  LOL.  A very committed bunch to say the least.  Prior to today, I haven't owned this stock since 2017.  

Feel the US is on the verge of dangling the legalization carrot as they are fighting for their lives with midterms. This will give the sentiment shift we (I can now say that) need.  

Also, with earnings coming next week, the stock has taken its beating.  Been researching this company since the week of Christmas. Given the market share drop, whats every one got for top line?  From my homework, It appears we'll do $165mm which would be below expectations.  

Anyhow interested to hear what you have for revenue forecasts.  I'm long as of $8.30 CDN (6k shares)


<< Previous
Bullboard Posts
Next >>